Technetium Tc 99M Tetrofosmin

CHEMBL1200857 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
899.8 g/mol
LogP
Phase
4

Technetium Tc 99m tetrofosmin is a lipophilic diphosphine radiopharmaceutical that accumulates in viable myocardium proportional to perfusion and mitochondrial membrane potential, used for myocardial perfusion SPECT imaging to evaluate coronary artery disease, assess myocardial viability, and risk-stratify patients with cardiovascular disease and hypertension. Its favorable dosimetry and imaging properties, with rapid blood clearance and low liver uptake, make it well-suited for same-day rest-stress protocols. It is one of the two most widely used myocardial perfusion agents alongside sestamibi.

分子量

899.8000 g/mol

TPSA

108.00 Ų

治療領域

作用機序

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

SMILES

CCOCC[PH+](CCOCC)CC[PH+](CCOCC)CCOCC.CCOCC[PH+](CCOCC)CC[PH+](CCOCC)CCOCC.O=[99Tc]=O

InChI

InChI=1S/2C18H40O4P2.2O.Tc/c2*1-5-19-9-13-23(14-10-20-6-2)17-18-24(15-11-21-7-3)16-12-22-8-4;;;/h2*5-18H2,1-4H3;;;/p+4/i;;;;1+1

Molecular Formula

C36H84O10P4Tc+4

HBD / HBA

- / 10

回転可能結合数

32

重原子数

51

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Technetium Tc 99m tetrofosmin is a lipophilic diphosphine radiopharmaceutical that accumulates in viable myocardium proportional to perfusion and mitochondrial membrane potential, used for myocardial perfusion SPECT imaging to evaluate coronary artery disease, assess myocardial viability, and risk-stratify patients with cardiovascular disease and hypertension. Its favorable dosimetry and imaging properties, with rapid blood clearance and low liver uptake, make it well-suited for same-day rest-stress protocols. It is one of the two most widely used myocardial perfusion agents alongside sestamibi.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Technetium Tc 99M Tetrofosmin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200857. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6326947. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.